Cibc Asset Management Inc Myriad Genetics Inc Transaction History

Cibc Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$15.26 - $23.75 $137,233 - $213,583	8,993 New	8,993 $208,000
Q4 2021 Feb 08, 2022	SELL	$24.13 - $32.63 $215,408 - $291,288	-8,927 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$29.97 - $36.66 $9,890 - $12,097	330 Added 3.84%	8,927 $288,000
Q1 2021 May 14, 2021	BUY	$19.92 - $31.6 $171,252 - $271,665	8,597 New	8,597 $262,000
Q4 2020 Feb 03, 2021	SELL	$12.16 - $19.77 $123,910 - $201,456	-10,190 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$11.25 - $14.75 $810 - $1,062	72 Added 0.71%	10,190 $133,000
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $211,769 - $355,141	10,118 New	10,118 $276,000
Q4 2017 Feb 02, 2018	SELL	$28.45 - $37.14 $243,503 - $317,881	-8,559 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$24.01 - $36.2 $205,501 - $309,835	8,559	8,559 $310,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.